The impact of COVID-19 disease on platelets and coagulation
GD Wool, JL Miller - Pathobiology, 2021 - karger.com
Abstract Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some
patients develop a severe proinflammatory state which can be associated with a unique …
patients develop a severe proinflammatory state which can be associated with a unique …
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as …
only mild symptoms in the majority of the cases, while immunologic complications such as …
Thrombosis and Coagulopathy in COVID-19
JE Gomez-Mesa, S Galindo-Coral, MC Montes… - Current problems in …, 2021 - Elsevier
Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) which initially
occurred in the city of Wuhan, located in China's Hubei province, spread around the world …
occurred in the city of Wuhan, located in China's Hubei province, spread around the world …
Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report
Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
Registry of arterial and venous thromboembolic complications in patients with COVID-19
Background Cardiovascular complications, including myocardial infarction, ischemic stroke,
and pulmonary embolism, represent an important source of adverse outcomes in …
and pulmonary embolism, represent an important source of adverse outcomes in …
Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review
Y Sakr, M Giovini, M Leone, G Pizzilli, A Kortgen… - Annals of intensive …, 2020 - Springer
Background Preliminary reports have described significant procoagulant events in patients
with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism …
with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism …
[HTML][HTML] Predictors of COVID-19 severity: a systematic review and meta-analysis
Background: The unpredictability of the progression of coronavirus disease 2019 (COVID-
19) may be attributed to the low precision of the tools used to predict the prognosis of this …
19) may be attributed to the low precision of the tools used to predict the prognosis of this …
Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research
B Bikdeli, MV Madhavan, A Gupta… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The …
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The …
Neutrophil extracellular traps (NETs) and damage‐associated molecular patterns (DAMPs): two potential targets for COVID‐19 treatment
S Cicco, G Cicco, V Racanelli… - Mediators of …, 2020 - Wiley Online Library
COVID‐19 is a pandemic disease caused by the new coronavirus SARS‐CoV‐2 that mostly
affects the respiratory system. The consequent inflammation is not able to clear viruses. The …
affects the respiratory system. The consequent inflammation is not able to clear viruses. The …
Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment
A Gąsecka, JA Borovac, RA Guerreiro… - … drugs and therapy, 2021 - Springer
Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …